The 5th International Inflammatory Breast Cancer Conference focuses on the unique biology and clinical course of inflammatory breast cancer, including the challenges of accurate identification and treatment, and the need to understand the molecular behavior of this disease that contribute to its distinctive presentation and outcomes. The rarity of inflammatory breast cancer warrants an international coalition of investigators to discuss recent advances in genomics, immunology, and the cancer microenvironment which may contribute to the development of inflammatory breast cancer. Focusing on clinical trial development specifically for inflammatory breast cancer is warranted in order to improve the clinical outcome of this virulent disease.
The primary goal of The 5th International Inflammatory Breast Cancer Conference is to bring together scientists and clinicians who are interested in understanding this unique disease, and to foster collaboration. This two-day symposium will offer exciting discussion on recent innovations in the multidisciplinary treatment of inflammatory breast cancer and explore scientific advances in breast cancer that can be applied to the understanding of this disease. In addition to presentations from experts in the field of breast cancer, interactive panel discussions and Q+A sessions will foster significant collaboration in the study of inflammatory breast cancer. The target audience includes medical oncologists, radiation oncologists, surgical oncologists, physician’s assistants, nurse practitioners, oncology nurses, physicians in training, and advocates.